Hong Kong Meiliduo Technology Limited
Retatrutide
Finnrick tested 5 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Hong Kong Meiliduo Technology Limited between 23 Apr 2026 and 13 Aug 2026. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Hong Kong Meiliduo Technology Limited
Retatrutide
Tested 5 Samples
Last test 13 Aug 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Hong Kong Meiliduo Technology Limited
Samples are tested in commercial labs
Tests Count
5
Scores
AVGMINMAX
Last
13 Aug 2026
First
23 Apr 2026
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 13 Aug 2026 | View | 30mg | 29.8mg | -0.7% | 99.80% | M202607RT30 | No label, Silver crimp, Clear cap | Lab G | Public | |
| 30 Jul 2026 | View | 20mg | 20.1mg | +0.5% | 99.80% | 5/3/2026 | No label / Silver crimp / White cap | Lab G | Public | |
| 26 Jun 2026 | View | 10mg | ⚠️ Sample does not contain Retatrutide | (no batch ID) | No label / Copper Silver crimp / White cap | Lab G | Public | |||
| 16 Jun 2026 | View | 20mg | 20.2mg | +1.0% | 99.90% | May 3, 2026 | No label / Silver crimp / White cap | Lab G | Public | |
| 23 Apr 2026 | View | 10mg | 11.3mg | +13.0% | 99.70% | (no batch ID) | Silver Label / Silver Crimp / Black Cap | Lab G | Public | |